Atlas Trials

Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial

Clinical trial NCT03253913 · COMPLETED

Trial details

NCT number
NCT03253913
Sponsor
University of Cincinnati
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphangioleiomyomatosis
Start date
2018-03-31
Primary completion
2022-10-15
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.